Skip to main content
. 2015 Aug 24;8:297–309. doi: 10.2147/IDR.S39186

Figure 5.

Figure 5

Comparative efficacy of a human-simulated dose of 2,000 mg aztreonam q6h (1-hour infusion) as monotherapy or combined with 375 mg avibactam q6h (ATM-AVI 375 mg) or 600 mg avibactam q6h (ATM-AVI 600 mg) against Enterobacteriaceae in a neutropenic-mouse thigh infection.

Note: Reproduced with permission from the American Society for Microbiology. Copyright © American Society for Microbiology. Crandon JL, Nicolau DP. Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-beta-lactamase producers. Antimicrob Agents Chemother. 2013;57(7):3299–3306.51

Abbreviations: ATM, aztreonam; AVI, avibactam; CFU, colony-forming units; EC, Escherichia coli; KP, Klebsiella pneumoniae.